Skip to main content
Top
Published in: AIDS and Behavior 3/2010

Open Access 01-06-2010 | original paper

Acceptability and Use of the Diaphragm and Replens® Lubricant Gel for HIV Prevention in Southern Africa

Authors: Elizabeth T. Montgomery, Helen Cheng, Ariane van der Straten, Agnes C. Chidanyika, Naomi Lince, Kelly Blanchard, Gita Ramjee, Busisiwe Nkala, Nancy S. Padian, The MIRA team

Published in: AIDS and Behavior | Issue 3/2010

Login to get access

Abstract

The acceptability and use of the diaphragm and lubricant gel were assessed as part of a large randomized controlled trial to determine the effectiveness of the methods in women’s HIV acquisition. 2,452 intervention-arm women were enrolled at five Southern African clinics and followed quarterly for 12–24 months. Acceptability and use data were collected by face-to-face interviews at Month 3 and Exit. Participants were “very comfortable” with the physical mechanics of diaphragm use throughout the trial, and approval of the gel consistency, quantity and the applicator was high. At Exit, consistent disclosure of use (AOR 1.97, 95% CI: 1.10–3.55); an overall high diaphragm rating (AOR 1.84, 95% CI: 1.45–2.34) and perception of partner approval (AOR 1.75, 95% CI: 1.35–2.26) were the most significant acceptability factors independently associated with consistent use. Despite being female-initiated, disclosure of use to male partners and his perceived approval of the products were factors significantly associated with their consistent use.
Literature
1.
go back to reference UNAIDS. AIDS epidemic update 2007, regional summary: sub-Saharan Africa. Geneva: UNAIDS; 2008. UNAIDS. AIDS epidemic update 2007, regional summary: sub-Saharan Africa. Geneva: UNAIDS; 2008.
2.
go back to reference UNAIDS/WHO. 2004 Report on the global AIDS epidemic, July 2004. UNAIDS/WHO. 2004 Report on the global AIDS epidemic, July 2004.
3.
go back to reference Gray R, Wawer M, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.CrossRefPubMed Gray R, Wawer M, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.CrossRefPubMed
4.
go back to reference European study group on heterosexual transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Brit Med J. 1992;304:809–13.CrossRef European study group on heterosexual transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Brit Med J. 1992;304:809–13.CrossRef
5.
go back to reference Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.CrossRefPubMed Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.CrossRefPubMed
6.
go back to reference Ramjee G, van der Straten A, Chipato T, et al. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS ONE. 2008;3(10):e3488.CrossRefPubMed Ramjee G, van der Straten A, Chipato T, et al. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS ONE. 2008;3(10):e3488.CrossRefPubMed
7.
go back to reference Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: where have we been? Where are we going? J Womens Health Gend Based Med. 2001;10(2):163–73.CrossRefPubMed Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: where have we been? Where are we going? J Womens Health Gend Based Med. 2001;10(2):163–73.CrossRefPubMed
8.
go back to reference Bulut A, Ortayli N, Ringheim K, et al. Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception. 2001;63(5):267–75.CrossRefPubMed Bulut A, Ortayli N, Ringheim K, et al. Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception. 2001;63(5):267–75.CrossRefPubMed
9.
go back to reference Ortayli N, Bulut A, Nalbant H, Cottingham J. Is the diaphragm a viable option for women in Turkey? Int Fam Plan Perspec. 2000;26(1):36–42.CrossRef Ortayli N, Bulut A, Nalbant H, Cottingham J. Is the diaphragm a viable option for women in Turkey? Int Fam Plan Perspec. 2000;26(1):36–42.CrossRef
10.
go back to reference Ravindran TKS, Rao S. Is the diaphragm a suitable method of contraception for low-income women: a user-perspective study, Madras, India. Beyond acceptability: user’s perspectives on contraception—out of print—a World Health Organization Monograph. 1997. Ravindran TKS, Rao S. Is the diaphragm a suitable method of contraception for low-income women: a user-perspective study, Madras, India. Beyond acceptability: user’s perspectives on contraception—out of print—a World Health Organization Monograph. 1997.
11.
go back to reference Barnhart KT, Rosenberg MJ, MacKay HT, et al. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Obstet Gynecol. 2007;110(3):577–86.PubMed Barnhart KT, Rosenberg MJ, MacKay HT, et al. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Obstet Gynecol. 2007;110(3):577–86.PubMed
12.
go back to reference Luchters S, Chersich MF, Jao I, et al. Acceptability of the diaphragm in Mombasa Kenya: a 6-month prospective study. Eur J Contracept Reprod Health Care. 2007;16:1–9. Luchters S, Chersich MF, Jao I, et al. Acceptability of the diaphragm in Mombasa Kenya: a 6-month prospective study. Eur J Contracept Reprod Health Care. 2007;16:1–9.
13.
go back to reference Guest G, Johnson L, Burke H, et al. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis. AIDS Educ Prev. 2007;19(4):310–20.CrossRefPubMed Guest G, Johnson L, Burke H, et al. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis. AIDS Educ Prev. 2007;19(4):310–20.CrossRefPubMed
14.
go back to reference Moon M, Khumalo-Sakutukwa G, Heiman J, Mbizvo M, Padian N. Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs. 2002;13(1):19–23.CrossRefPubMed Moon M, Khumalo-Sakutukwa G, Heiman J, Mbizvo M, Padian N. Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs. 2002;13(1):19–23.CrossRefPubMed
15.
go back to reference Pool R, Whitworth JA, Green G, et al. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD AIDS. 2000;11(3):162–7.CrossRefPubMed Pool R, Whitworth JA, Green G, et al. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD AIDS. 2000;11(3):162–7.CrossRefPubMed
16.
go back to reference Behets F, Turner A, Van Damme K, et al. Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. Sex Transm Infect. 2005;81(6):472–6.CrossRefPubMed Behets F, Turner A, Van Damme K, et al. Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. Sex Transm Infect. 2005;81(6):472–6.CrossRefPubMed
17.
go back to reference Ramjee G, Gouws E, Andrews A, Myer L, Weber A. The acceptability of vaginal microbicide among South African men. Int Fam Plann Perspec. 2001;27(4):164–70.CrossRef Ramjee G, Gouws E, Andrews A, Myer L, Weber A. The acceptability of vaginal microbicide among South African men. Int Fam Plann Perspec. 2001;27(4):164–70.CrossRef
18.
go back to reference Bird S, Harvey S, Maher J, Beckman L. Acceptability of an existing, female-controlled contraceptive method that could potentially protect against HIV: a comparison of diaphragm users and other method users. Women Health Iss. 2004;14(3):85–93.CrossRef Bird S, Harvey S, Maher J, Beckman L. Acceptability of an existing, female-controlled contraceptive method that could potentially protect against HIV: a comparison of diaphragm users and other method users. Women Health Iss. 2004;14(3):85–93.CrossRef
19.
go back to reference Buck J, Kang MS, van der Straten A, et al. Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav. 2005;9(4):1–8. Buck J, Kang MS, van der Straten A, et al. Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav. 2005;9(4):1–8.
20.
go back to reference Harvey S, Bird S, Maher J, Beckman L. Who continues using the diaphragm and who doesn’t: implications for the acceptability of female-controlled HIV prevention methods. Women Health Iss. 2003;13(5):185–93.CrossRef Harvey S, Bird S, Maher J, Beckman L. Who continues using the diaphragm and who doesn’t: implications for the acceptability of female-controlled HIV prevention methods. Women Health Iss. 2003;13(5):185–93.CrossRef
21.
go back to reference van der Straten A, Kang M, Posner S, et al. Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis. 2005;32(1):64–71.CrossRefPubMed van der Straten A, Kang M, Posner S, et al. Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis. 2005;32(1):64–71.CrossRefPubMed
22.
go back to reference Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health. 2004;94(7):1159–64.CrossRefPubMed Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health. 2004;94(7):1159–64.CrossRefPubMed
23.
go back to reference Coggins C, Blanchard K, Friedland B. Men’s attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reprod Health Matters. 2000;8(15):132–41.CrossRefPubMed Coggins C, Blanchard K, Friedland B. Men’s attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reprod Health Matters. 2000;8(15):132–41.CrossRefPubMed
24.
go back to reference van de Wijgert J, Khumalo-Sakutukwa G, Coggins C, et al. Men’s attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. Int Fam Plan Perspec. 1999;25(1):15–20.CrossRef van de Wijgert J, Khumalo-Sakutukwa G, Coggins C, et al. Men’s attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. Int Fam Plan Perspec. 1999;25(1):15–20.CrossRef
25.
go back to reference van der Straten A, Moore J, Napierala S, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbice in Harare, Zimbabwe. Contraception. 2008;77(6):435–43.CrossRefPubMed van der Straten A, Moore J, Napierala S, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbice in Harare, Zimbabwe. Contraception. 2008;77(6):435–43.CrossRefPubMed
26.
go back to reference Minnis A, Shiboski S, Padian N. Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex Transm Dis. 2003;30(7):556–61.CrossRefPubMed Minnis A, Shiboski S, Padian N. Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex Transm Dis. 2003;30(7):556–61.CrossRefPubMed
27.
go back to reference Catania JA, Binson D, van der Straten A, Stone V. Methodological research on sexual behavior in the AIDS era. In: Rosen RC, Davis CM, Ruppel JHJ, editors. Annual review of sex research, vol. 6. Mt. Vernon, IA: Society for the Scientific Study of Sexuality; 1995. p. 77–125. Catania JA, Binson D, van der Straten A, Stone V. Methodological research on sexual behavior in the AIDS era. In: Rosen RC, Davis CM, Ruppel JHJ, editors. Annual review of sex research, vol. 6. Mt. Vernon, IA: Society for the Scientific Study of Sexuality; 1995. p. 77–125.
28.
go back to reference Mantell JE, Stein ZA, Susser I. Women in the time of AIDS: barriers, bargains, and benefits. AIDS Educ Prev. 2008;20(2):91–106.CrossRefPubMed Mantell JE, Stein ZA, Susser I. Women in the time of AIDS: barriers, bargains, and benefits. AIDS Educ Prev. 2008;20(2):91–106.CrossRefPubMed
29.
go back to reference Philpott A, Knerr W, Maher D. Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. Lancet. 2006;368(9551):2028–31.CrossRefPubMed Philpott A, Knerr W, Maher D. Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. Lancet. 2006;368(9551):2028–31.CrossRefPubMed
30.
go back to reference Hammett TM, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities. Sex Transm Dis. 2000;27(2):119–26.CrossRefPubMed Hammett TM, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities. Sex Transm Dis. 2000;27(2):119–26.CrossRefPubMed
31.
go back to reference Woodsong C. Covert use of topical microbicides: implications for acceptability and use. Int Fam Plan Perspec. 2004;30(2):94–8.CrossRef Woodsong C. Covert use of topical microbicides: implications for acceptability and use. Int Fam Plan Perspec. 2004;30(2):94–8.CrossRef
32.
go back to reference Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.CrossRefPubMed Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.CrossRefPubMed
33.
go back to reference Montgomery E, Musara P, Chandipiswa A, et al. Safety of the Duet® used continuously or pre-coitally in Zimbabwean women International AIDS society conference on HIV pathogenesis, treatment and prevention. Vol Cape Town, South Africa 2009. Montgomery E, Musara P, Chandipiswa A, et al. Safety of the Duet® used continuously or pre-coitally in Zimbabwean women International AIDS society conference on HIV pathogenesis, treatment and prevention. Vol Cape Town, South Africa 2009.
34.
go back to reference van der Straten A, Cheng H, Moore J, et al. The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav. 2009;13:564–572. van der Straten A, Cheng H, Moore J, et al. The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav. 2009;13:564–572.
35.
go back to reference van der Straten A, Shiboski S, Montgomery ET, et al. Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquire Immune Defic Syndr. 2009;50(4):419–26.CrossRef van der Straten A, Shiboski S, Montgomery ET, et al. Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquire Immune Defic Syndr. 2009;50(4):419–26.CrossRef
36.
go back to reference Weiss HA, Wasserheit JN, Barnabas RV, et al. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Theme Epidemiol. 2008;2008(5):9. Weiss HA, Wasserheit JN, Barnabas RV, et al. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Theme Epidemiol. 2008;2008(5):9.
Metadata
Title
Acceptability and Use of the Diaphragm and Replens® Lubricant Gel for HIV Prevention in Southern Africa
Authors
Elizabeth T. Montgomery
Helen Cheng
Ariane van der Straten
Agnes C. Chidanyika
Naomi Lince
Kelly Blanchard
Gita Ramjee
Busisiwe Nkala
Nancy S. Padian
The MIRA team
Publication date
01-06-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9609-z

Other articles of this Issue 3/2010

AIDS and Behavior 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.